Stem Cell Research & Therapy

tracked for impact factor

Commentary

Mesenchymal stem cells immunosuppressive properties: is it specific to bone marrow-derived cells?

Christian Jorgensen

Author Affiliations

Inserm, U 844, Hôpital Saint-Eloi, Montpellier, F-34295 France

Université MONTPELLIER1, UFR de Médecine, Montpellier, F-34967 France

Service thérapeutique des maladies ostéoarticulaires, Hôpital Lapeyronie, Montpellier, F-34295 France

Stem Cell Research & Therapy 2010, 1:15 doi:10.1186/scrt15

Published: 8 June 2010

Abstract

Based on their capacity to suppress immune responses, multipotent mesenchymal stromal cells (MSCs) are intensively studied for regenerative medicine. Moreover, MSCs have paracrine effects, including immunomodulation that occurs through the secretion of soluble mediators, including nitric oxide or interleukin-6, transforming growth factor-beta, human leukocyte antigen G5, and prostaglandin E2. MSCs in the bone marrow are in close contact with T and B cells and regulate immunological memory by organizing defined numbers of dedicated survival niches for plasma cells and memory T cells in the bone marrow. All of these biological effects are probably shared by all stromal cells, including fibroblasts and stem cells isolated from exfoliated deciduous teeth. The therapeutical implications are discussed.